Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Rabaneda-Lombarte

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|August 9, 2023
Malignant psoas syndrome and bilateral hydronephrosis without evident obstruction in colorectal cancerNeus Rabaneda-Lombarte, Eugeniu Grama, Niccolo Viveros, et al.
Frontiers in Molecular Neuroscience|January 29, 2019
Parkinsonian Neurotoxins Impair the Pro-inflammatory Response of Glial CellsNeus Rabaneda-Lombarte, Efren Xicoy-Espaulella, Joan Serratosa, et al.
Journal of Neuroinflammation|April 7, 2021
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's diseaseNeus Rabaneda-Lombarte, Joan Serratosa, Jordi Bové, et al.
Scientific Reports|July 2, 2020
Parkinsonian neurotoxicants impair the anti-inflammatory response induced by IL4 in glial cells: involvement of the CD200-CD200R1 ligand-receptor pairNeus Rabaneda-Lombarte, Lucas Blasco-Agell, Joan Serratosa, et al.
Frontiers in Immunology|July 18, 2024
Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkersNeus Rabaneda-Lombarte, Aina Teniente-Serra, Anna Massuet-Vilamajó, et al.
Plos Genetics|October 5, 2017
A C-terminally truncated form of β-catenin acts as a novel regulator of Wnt/β-catenin signaling in planariansHanxia Su, Miquel Sureda-Gomez, Neus Rabaneda-Lombarte, et al.
Eclinicalmedicine|April 30, 2026
Real-world comparison of brain [<sup>18</sup>F]FDG-PET imaging with CSF Alzheimer's disease biomarkers in a tertiary memory clinic settingNeus Rabaneda-Lombarte, João Pedro Ferrari-Souza, Johanna Celedon, et al.
NPJ Parkinson'S Disease|March 17, 2022
Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson's disease patientsNeus Rabaneda-Lombarte, José Manuel Vidal-Taboada, Tony Valente, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMethasit Jaisa-Aad, Cinthya Aguero, Neus Rabaneda-Lombarte, et al.
Alzheimer'S Research & Therapy|October 15, 2024
Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodiesAnna Planas-Ballvé, Jose Rios, Mireia Gea, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|August 9, 2023
Malignant psoas syndrome and bilateral hydronephrosis without evident obstruction in colorectal cancerNeus Rabaneda-Lombarte, Eugeniu Grama, Niccolo Viveros, et al.
Frontiers in Molecular Neuroscience|January 29, 2019
Parkinsonian Neurotoxins Impair the Pro-inflammatory Response of Glial CellsNeus Rabaneda-Lombarte, Efren Xicoy-Espaulella, Joan Serratosa, et al.
Journal of Neuroinflammation|April 7, 2021
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's diseaseNeus Rabaneda-Lombarte, Joan Serratosa, Jordi Bové, et al.
Scientific Reports|July 2, 2020
Parkinsonian neurotoxicants impair the anti-inflammatory response induced by IL4 in glial cells: involvement of the CD200-CD200R1 ligand-receptor pairNeus Rabaneda-Lombarte, Lucas Blasco-Agell, Joan Serratosa, et al.
Frontiers in Immunology|July 18, 2024
Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkersNeus Rabaneda-Lombarte, Aina Teniente-Serra, Anna Massuet-Vilamajó, et al.
Plos Genetics|October 5, 2017
A C-terminally truncated form of β-catenin acts as a novel regulator of Wnt/β-catenin signaling in planariansHanxia Su, Miquel Sureda-Gomez, Neus Rabaneda-Lombarte, et al.
Eclinicalmedicine|April 30, 2026
Real-world comparison of brain [<sup>18</sup>F]FDG-PET imaging with CSF Alzheimer's disease biomarkers in a tertiary memory clinic settingNeus Rabaneda-Lombarte, João Pedro Ferrari-Souza, Johanna Celedon, et al.
NPJ Parkinson'S Disease|March 17, 2022
Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson's disease patientsNeus Rabaneda-Lombarte, José Manuel Vidal-Taboada, Tony Valente, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMethasit Jaisa-Aad, Cinthya Aguero, Neus Rabaneda-Lombarte, et al.
Alzheimer'S Research & Therapy|October 15, 2024
Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodiesAnna Planas-Ballvé, Jose Rios, Mireia Gea, et al.
Pageof 2